Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01568424 · ClinicalTrials.gov registry record · NA
CentriMag RVAS U.S. Post-approval Study Protocol
A NA study, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT01568424 is a NA study that has completed, run by Abbott Medical Devices. The registered enrollment target is 25 participants.
The verdict
NCT01568424, a NA study, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
The study objective is to gather post-market clinical data on the use of the CentriMag RVAS when used for temporary mechanical circulatory support of the right ventricle in patients with acute right ventricular failure from any cause
Interventions
- DEVICE CentriMag RVAS placement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2009-09 |
| Est. Completion | 2014-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01568424
The ClinicalTrials.gov registry entry for NCT01568424 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CentriMag RVAS placement is the first listed.
NCT01568424 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01568424 about?
NCT01568424 is a clinical study titled "CentriMag RVAS U.S. Post-approval Study Protocol". The study objective is to gather post-market clinical data on the use of the CentriMag RVAS when used for temporary mechanical circulatory support of the right ventricle in patients with acute right ventricular failure from any cause
What is the current status of trial NCT01568424?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2009-09. Estimated completion is 2014-06.
What interventions are being tested in trial NCT01568424?
The interventions under investigation include: CentriMag RVAS placement (DEVICE).
Who is sponsoring clinical trial NCT01568424?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.